Spamdex - Spam Archive

Report spam

Send in your spam and get the offenders listed

Create a rule in outlook or simply forward the spam you receive to

Also in

The 10-Point: My Guide to the Day's Top News.

The Wall Street Journal
Good morning,
A New Frontline
The U.S. will have a new base from which to attack Islamic State. After months of tense negotiations, Turkey has agreed to allow the U.S. to launch fighter jets and armed drones from the country’s Incirlik Air Base, which until now has been used by the U.S. only to fly out unarmed surveillance drones. The move comes after attacks in Turkey killed dozens of people this week and amid increasing threats against the country from Islamic State. Turkish jets attacked Islamic State positions in Syria for the first time today as security forces launched nationwide dawn raids against the group’s network. Meanwhile, we report that despite international efforts last year to rid Syrian President Bashar al-Assad’s regime of chemical munitions that resulted in the removal of 1,300 metric tons of weapons-grade chemicals, intelligence officials believe it didn’t give everything up.
Prime Numbers
Amazon surprised investors by reporting a narrow profit, sending shares more than 17% higher in after-hours trading and pushing the online retail giant’s market value to about $264 billion, well past that of rival Wal-Mart. Strong sales growth at its cloud-computing division and better cost control helped the Seattle company beat analysts’ expectations of a second-quarter loss. Amazon has been criticized for its big losses, but the reaction to the $92 million profit on $23.18 billion in sales is a reminder of the modest income expectations for the company and will likely spur the question of whether this is the new normal.
A Healthy Bet
The Affordable Care Act may have served as political ammunition for some of U.S. President Barack Obama’s opponents, but one hedge fund saw it as something else—a smart investment. Glenview Capital Management laid the groundwork early, deciding as far back as 2007 that the health-care landscape was likely to shift, resulting in mergers for hospital companies and insurers—a wager that has given it more than $3.2 billion in realized and paper gains. Glenview owns shares in Aetna and Humana, which struck a $34 billion deal earlier this month, and its latest payday is expected from Anthem and Cigna, which today confirmed a $48 billion-plus tie-up.
Jefferson Davis Slept Here
Antebellum homes are experiencing something of a renaissance. Prices for historic houses near Civil War battle sites in several areas are rising, and inventory is moving faster than the national average, we report. Such real estate can be especially enticing to history buffs and Civil War re-enactors, for whom finding treasures from the period around the property can be an added bonus to proximity to battle sites. Owning these relics isn’t for everyone—annual maintenance costs can run into six figures and the pool of buyers tends to be small when it’s time to sell.

Investigation Sought Into Hillary Clinton’s Emails

Denver Job Market Lures Millennials

U.S.-Trained Iraqi Forces Deploy Near Ramadi

British Teen Admits to Advising on Australian Terrorism Plot

Anglo American to Slash 53,000 Jobs

SEC Investigating Smirnoff Maker Diageo

Copper, Aluminum Prices Follow Gold’s Wake to Hit Multiyear Lows

U.S. Authorities Probe Banks’ Handling of FIFA Funds
NASA Finds Most Earth-Like Planet Yet
That Was Painless
At 1,400 light years away from Earth, scientists said they have discovered a planet they believe is the closest twin to our world ever found. Photo: NASA/JPL-Caltech/T. Pyle
$1.2 billion
General Motors’ world-wide profit for the second quarter, up from $278 million a year ago when recalls and quality concerns weighed on earnings.
I think I’ll win the Hispanic vote.
Donald Trump on a visit to the U.S.-Mexico border, also saying he would win the Republican Party’s 2016 presidential nomination.
What do you think about Mr. Trump’s comments on winning the GOP nomination? Send your comments, which we may edit before publication, to Please include your name and location.
—Compiled by Yogita Patel
On yesterday’s question about cancer drug prices, Leonard Wojtecki of Illinois wrote: “I have a rare cancer in my esophagus which has spread to my liver and lymph nodes. It’s inoperable and incurable in its present stage. The cancer is now beginning to spread again. My oncologist explained my options, one of which involves a very promising clinical trial involving a drug that so far had good results. He said it wasn’t covered by insurance though and that I would have to pay for it myself. The cost is a million dollars a year. Why do the drug companies hold out hope when there isn’t any?” Susan Day of Pennsylvania commented: “Why are U.S. patients footing the bill for all of the research needs? For the same drug, patients in Europe pay a controlled price set by each government, once a government body has determined that a new drug is actually better—including an evaluation of any cost differences with the better benefits—than the drug it’s replacing.” Gregory F. Weaver weighed in from Texas: “R&D funding for new drugs is critical and must continue. What realm needs to be analyzed in depth is the markup of these drugs at the hospital level.” Robert J. Boyd, M.D., wrote from Massachusetts: “This needs serious review by a group of knowledgeable experts, preferably non-political in nature, such as the Institute of Medicine. We must determine the true nature and magnitude of the situation, and alternative ways to deal with this growing and very serious problem.”
This daily briefing is named "The 10-Point" after the nickname conferred by the editors of The Wall Street Journal on the lead column of the legendary "What's News" digest of top stories. Technically, "10-point" referred to the size of the typeface. The type is smaller now but the name lives on.
Email Settings Contact Us Privacy Policy Cookie Policy
You are currently subscribed as . For further assistance, please contact Customer Service at
Copyright 2015 Dow Jones & Company, Inc. All Rights Reserved.   


All titles, content, publisher names, trademarks, artwork, and associated imagery are trademarks and/or copyright material of their respective owners. All rights reserved. The Spam Archive website contains material for general information purposes only. It has been written for the purpose of providing information and historical reference containing in the main instances of business or commercial spam.

Many of the messages in Spamdex's archive contain forged headers in one form or another. The fact that an email claims to have come from one email address or another does not mean it actually originated at that address! Please use spamdex responsibly.

Yes YOU! Get INVOLVED - Send in your spam and report offenders

Create a rule in outlook or simply forward the junk email you receive to | See contributors

Google + Spam 2010- 2017 Spamdex - The Spam Archive for the internet. unsolicited electric messages (spam) archived for posterity. Link to us and help promote Spamdex as a means of forcing Spammers to re-think the amount of spam they send us.

The Spam Archive - Chronicling spam emails into readable web records index for all time

Please contact us with any comments or questions at Spam Archive is a non-profit library of thousands of spam email messages sent to a single email address. A number of far-sighted people have been saving all their spam and have put it online. This is a valuable resource for anyone writing Bayesian filters. The Spam Archive is building a digital library of Internet spam. Your use of the Archive is subject to the Archive's Terms of Use. All emails viewed are copyright of the respected companies or corporations. Thanks to Benedict Sykes for assisting with tech problems and Google Indexing, ta Ben.

Our inspiration is the "Internet Archive" USA. "Libraries exist to preserve society's cultural artefacts and to provide access to them. If libraries are to continue to foster education and scholarship in this era of digital technology, it's essential for them to extend those functions into the digital world." This is our library of unsolicited emails from around the world. See Spamdex is in no way associated though. Supporters and members of Helping rid the internet of spam, one email at a time. Working with Inernet Aware to improve user knowlegde on keeping safe online. Many thanks to all our supporters including Vanilla Circus for providing SEO advice and other content syndication help | Link to us | Terms | Privacy | Cookies | Complaints | Copyright | Spam emails / ICO | Spam images | Sitemap | All hosting and cloud migration by Cloudworks.

Important: Users take note, this is Spamdex - The Spam Archive for the internet. Some of the pages indexed could contain offensive language or contain fraudulent offers. If an offer looks too good to be true it probably is! Please tread, carefully, all of the links should be fine. Clicking I agree means you agree to our terms and conditions. We cannot be held responsible etc etc.

The Spam Archive - Chronicling spam emails into readable web records

The Glass House | London | SW19 8AE |
Spamdex is a digital archive of unsolicited electronic mail 4.9 out of 5 based on reviews
Spamdex - The Spam Archive Located in London, SW19 8AE. Phone: 08000 0514541.